Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy.
FDG uptake
breast cancer
gene signature
immunosuppression
radiotherapy
Journal
Molecular therapy oncolytics
ISSN: 2372-7705
Titre abrégé: Mol Ther Oncolytics
Pays: United States
ID NLM: 101666776
Informations de publication
Date de publication:
17 Dec 2021
17 Dec 2021
Historique:
received:
12
05
2021
revised:
27
09
2021
accepted:
18
10
2021
entrez:
2
12
2021
pubmed:
3
12
2021
medline:
3
12
2021
Statut:
epublish
Résumé
Radiotherapy (RT) is a major modality of postoperative treatment in breast cancer. The maximal standardized value (SUVmax) is
Identifiants
pubmed: 34853812
doi: 10.1016/j.omto.2021.10.008
pii: S2372-7705(21)00145-5
pmc: PMC8605077
doi:
Types de publication
Journal Article
Langues
eng
Pagination
412-419Informations de copyright
© 2021 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no competing interests.
Références
Clin Cancer Res. 2015 Aug 15;21(16):3667-77
pubmed: 25904749
Radiother Oncol. 2014 Aug;112(2):302-7
pubmed: 25150637
Nat Metab. 2020 Oct;2(10):1001-1012
pubmed: 32958939
J Nucl Med. 2010 Apr;51(4):543-50
pubmed: 20237034
Hum Pathol. 2018 May;75:81-90
pubmed: 29447919
Clin Cancer Res. 2012 Mar 15;18(6):1704-15
pubmed: 22271875
EMBO J. 2020 Oct 1;39(19):e104063
pubmed: 32790115
Clin Cancer Res. 2018 Oct 1;24(19):4754-4762
pubmed: 29921729
Cancer Res Treat. 2020 Jan;52(1):85-97
pubmed: 31122008
Lancet Oncol. 2017 Feb;18(2):202-211
pubmed: 27993569
Breast Cancer Res. 2018 Jul 4;20(1):64
pubmed: 29973242
Lancet. 2011 Nov 12;378(9804):1707-16
pubmed: 22019144
Mol Cancer Ther. 2015 Aug;14(8):1794-804
pubmed: 26063767
Cancer Res. 2011 Aug 1;71(15):5164-74
pubmed: 21646475
Cell. 2010 Nov 24;143(5):711-24
pubmed: 21074248
Breast Cancer Res. 2008;10(2):R34
pubmed: 18430221
Cancer Cell. 2019 Mar 18;35(3):428-440.e5
pubmed: 30853353
Nature. 2002 Jan 31;415(6871):530-6
pubmed: 11823860
J Nucl Med. 2008 Mar;49(3):480-508
pubmed: 18287273
Cell Metab. 2018 May 01;27(5):977-987.e4
pubmed: 29628419
Clin Cancer Res. 2012 Oct 15;18(20):5585-94
pubmed: 23071360
Cancer Res. 2011 Nov 15;71(22):6921-5
pubmed: 22084445
Clin Nucl Med. 2017 Jul;42(7):506-513
pubmed: 28481792
Radiother Oncol. 2009 Apr;91(1):85-94
pubmed: 19100641
Eur J Nucl Med Mol Imaging. 2002 Oct;29(10):1317-23
pubmed: 12271413
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Breast. 2016 Dec;30:5-12
pubmed: 27569020
Cell. 2015 Sep 10;162(6):1217-28
pubmed: 26321681
Clin Cancer Res. 2014 Oct 15;20(20):5272-80
pubmed: 25149560
EJNMMI Res. 2018 Jan 18;8(1):4
pubmed: 29349517
Nat Rev Cancer. 2020 Sep;20(9):516-531
pubmed: 32632251
Br J Surg. 2009 Feb;96(2):166-70
pubmed: 19160365
Genomics. 2004 Dec;84(6):1014-20
pubmed: 15533718
J Nucl Med. 2008 Jun;49 Suppl 2:24S-42S
pubmed: 18523064
Nat Rev Cancer. 2010 Apr;10(4):267-77
pubmed: 20300106
Lancet. 2017 Mar 18;389(10074):1134-1150
pubmed: 27865536
Lancet. 2014 Jun 21;383(9935):2127-35
pubmed: 24656685
Ann Surg Oncol. 2019 Jul;26(7):2175-2183
pubmed: 30941655
N Engl J Med. 2002 Dec 19;347(25):1999-2009
pubmed: 12490681